Announce Date | 07/28/2025 |
EPS Normalized Actual | $1.49 (Beat by $0.15) |
EPS GAAP Actual | $1.49 (Beat by $0.15) |
Revenue Actual | $0.5772B |
Revenue Surprise | Beat by $577.2M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.42816 |
EPS GAAP Estimate | $1.42816 |
Revenue Estimate | $0.600116577B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 8.49 | 21.57 | 8.38379 | 8.62462 | 1 |
Dec 2028 | 7.48 | 24.48 | 7.40236 | 7.53202 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.48 | 0.12797 | 0.5772B | -0.69% | -10.35M |
FQ1 2025 (Mar 2025) | 1.83 | 1.83 | 0.5576B | -1.38% | 557.6M |
FQ4 2024 (Dec 2024) | 1.41 | 1.41 | 0.5441B | 34.41% | 544.1M |
FQ3 2024 (Sep 2024) | 1.35 | 1.35 | 0.5972B | 11.24% | 597.2M |
FQ2 2024 (Jun 2024) | 1.25 | 1.25 | 0.5812B | 12.32% | 581.2M |
FQ1 2024 (Mar 2024) | 1.12 | 1.12 | 0.5653B | -49.11% | 565.3M |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 0.3569B | -130.91% | 356.9M |
FQ3 2023 (Sep 2023) | 0.97 | 0.97 | 0.5301B | -53.76% | 530.1M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.42816
Consensus Revenue Estimates
0.600116577B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.99715 | -- | 1.9846 | 2.0149 | 2 |
FQ3 2027 (Sep 2027) | 1.87336 | -- | 1.8576 | 1.88441 | 1 |
FQ2 2027 (Jun 2027) | 1.7935 | -- | 1.77841 | 1.80408 | 1 |
FQ1 2027 (Mar 2027) | 1.67286 | -- | 1.65955 | 1.68196 | 1 |
FQ4 2026 (Oct 2026) | 1.69595 | -- | 1.66091 | 1.72332 | 0 |
FQ3 2026 (Jul 2026) | 1.55987 | -- | 1.52764 | 1.58504 | 0 |
FQ2 2026 (Jun 2026) | 1.51309 | 2.19 | 1.49437 | 1.5312 | 0 |
FQ1 2026 (Mar 2026) | 1.47185 | -24.33 | 1.45364 | 1.48946 | 0 |
FQ4 2025 (Oct 2025) | 1.51053 | 6.66 | 1.47932 | 1.53491 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.72B | -- | 0.72B | 0.73B | 2 |
FQ3 2027 (Sep 2027) | 0.67B | -- | 0.66B | 0.67B | 2 |
FQ2 2027 (Jun 2027) | 0.64B | -- | 0.64B | 0.64B | 2 |
FQ1 2027 (Mar 2027) | 0.62B | -- | 0.62B | 0.62B | 2 |
FQ4 2026 (Oct 2026) | 0.65B | -- | 0.64B | 0.66B | 1 |
FQ3 2026 (Jul 2026) | 0.63B | -- | 0.62B | 0.64B | 1 |
FQ2 2026 (Jun 2026) | 0.62B | 6.39 | 0.61B | 0.62B | 1 |
FQ1 2026 (Mar 2026) | 0.61B | 9.01 | 0.61B | 0.62B | 1 |
FQ4 2025 (Oct 2025) | 0.62B | 12.59 | 0.61B | 0.63B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.35203 | 1.48 | 0.12797 | 8.65% |
FQ1 2025 (Mar 2025) | 1.83 | 1.83 | 100% | |
FQ4 2024 (Dec 2024) | 1.41 | 1.41 | 100% | |
FQ3 2024 (Sep 2024) | 1.35 | 1.35 | 100% | |
FQ2 2024 (Jun 2024) | 1.25 | 1.25 | 100% | |
FQ1 2024 (Mar 2024) | 1.12 | 1.12 | 100% | |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 100% | |
FQ3 2023 (Sep 2023) | 0.97 | 0.97 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.59B | $0.58B | $-10.35M | -1.79% |
FQ1 2025 (Mar 2025) | $0B | $0.56B | $557.6M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.54B | $544.1M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.6B | $597.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.58B | $581.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.57B | $565.3M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.36B | $356.9M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.53B | $530.1M | 100% |